The global burden of ischemic heart disease attributed to high fasting plasma glucose: Data from 1990 to 2019

Background: Ischemic heart disease (IHD) is the leading cause of death worldwide. High fasting plasma glucose (FPG) is an increasing risk factor for IHD. We aimed to explore the long-term trends of high FPG-attributed IHD mortality during 1990–2019. Methods: Data were obtained from the Global Burden...

Full description

Bibliographic Details
Main Authors: Nirui Shen, Jin Liu, Yan Wang, Yuanjie Qiu, Danyang Li, Qingting Wang, Limin Chai, Yuqian Chen, Huizhong Hu, Manxiang Li
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024030962
_version_ 1797259770162315264
author Nirui Shen
Jin Liu
Yan Wang
Yuanjie Qiu
Danyang Li
Qingting Wang
Limin Chai
Yuqian Chen
Huizhong Hu
Manxiang Li
author_facet Nirui Shen
Jin Liu
Yan Wang
Yuanjie Qiu
Danyang Li
Qingting Wang
Limin Chai
Yuqian Chen
Huizhong Hu
Manxiang Li
author_sort Nirui Shen
collection DOAJ
description Background: Ischemic heart disease (IHD) is the leading cause of death worldwide. High fasting plasma glucose (FPG) is an increasing risk factor for IHD. We aimed to explore the long-term trends of high FPG-attributed IHD mortality during 1990–2019. Methods: Data were obtained from the Global Burden of Disease Study 2019 database. Deaths, disability-adjusted life-years (DALYs), the age-standardized mortality rate (ASMR) and age-standardized DALY rate (ASDR) of IHD attributable to high FPG were estimated by sex, socio-demographic index (SDI), regions and age. Estimated annual percentage changes (EAPCs) were calculated to assess the trends of ASMR and ASDR of IHD attributable to high FPG. Results: IHD attributable to high FPG deaths increased from 1.04 million (0.62–1.63) in 1990 to 2.35 million (1.4–3.7) in 2019, and the corresponding DALYs rose from 19.82 million (12.68–29.4) to 43.3 million (27.8–64.2). In 2019, ASMR and ASDR of IHD burden attributable to high FPG were 30.45 (17.09–49.03) and 534.8 (340.7–792.2), respectively. The highest ASMR and ASDR of IHD attributable to high FPG occurred in low-middle SDI quintiles, with 39.28 (22.40–62.76) and 742.3 (461.5–1117.5), respectively, followed by low SDI quintiles and middle SDI quintiles. Males had higher ASMR and ASDR compared to females across the past 30 years. In addition, ASRs of DALYs and deaths were highest in those over 95 years old. Conclusion: High FPG-attributed IHD mortality and DALYs have increased dramatically and globally, particularly in low, low-middle SDI quintiles and among the elderly. High FPG remains a great concern on the global burden of IHD and effective prevention and interventions are urgently needed to curb the ranking IHD burden, especially in lower SDI regions.
first_indexed 2024-04-24T23:14:42Z
format Article
id doaj.art-216126660d2e41828f5a1e887e32aa0e
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-04-24T23:14:42Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-216126660d2e41828f5a1e887e32aa0e2024-03-17T07:57:13ZengElsevierHeliyon2405-84402024-03-01105e27065The global burden of ischemic heart disease attributed to high fasting plasma glucose: Data from 1990 to 2019Nirui Shen0Jin Liu1Yan Wang2Yuanjie Qiu3Danyang Li4Qingting Wang5Limin Chai6Yuqian Chen7Huizhong Hu8Manxiang Li9Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, ChinaDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, ChinaDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, ChinaDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, ChinaDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, ChinaDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, ChinaDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, ChinaDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, ChinaDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, ChinaCorresponding author. Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, No. 277, West Yanta Road, Xi'an, Shaanxi 710061, China.; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, ChinaBackground: Ischemic heart disease (IHD) is the leading cause of death worldwide. High fasting plasma glucose (FPG) is an increasing risk factor for IHD. We aimed to explore the long-term trends of high FPG-attributed IHD mortality during 1990–2019. Methods: Data were obtained from the Global Burden of Disease Study 2019 database. Deaths, disability-adjusted life-years (DALYs), the age-standardized mortality rate (ASMR) and age-standardized DALY rate (ASDR) of IHD attributable to high FPG were estimated by sex, socio-demographic index (SDI), regions and age. Estimated annual percentage changes (EAPCs) were calculated to assess the trends of ASMR and ASDR of IHD attributable to high FPG. Results: IHD attributable to high FPG deaths increased from 1.04 million (0.62–1.63) in 1990 to 2.35 million (1.4–3.7) in 2019, and the corresponding DALYs rose from 19.82 million (12.68–29.4) to 43.3 million (27.8–64.2). In 2019, ASMR and ASDR of IHD burden attributable to high FPG were 30.45 (17.09–49.03) and 534.8 (340.7–792.2), respectively. The highest ASMR and ASDR of IHD attributable to high FPG occurred in low-middle SDI quintiles, with 39.28 (22.40–62.76) and 742.3 (461.5–1117.5), respectively, followed by low SDI quintiles and middle SDI quintiles. Males had higher ASMR and ASDR compared to females across the past 30 years. In addition, ASRs of DALYs and deaths were highest in those over 95 years old. Conclusion: High FPG-attributed IHD mortality and DALYs have increased dramatically and globally, particularly in low, low-middle SDI quintiles and among the elderly. High FPG remains a great concern on the global burden of IHD and effective prevention and interventions are urgently needed to curb the ranking IHD burden, especially in lower SDI regions.http://www.sciencedirect.com/science/article/pii/S2405844024030962Ischemic heart diseaseHigh fasting plasma glucoseMortalityDisability-adjusted life years
spellingShingle Nirui Shen
Jin Liu
Yan Wang
Yuanjie Qiu
Danyang Li
Qingting Wang
Limin Chai
Yuqian Chen
Huizhong Hu
Manxiang Li
The global burden of ischemic heart disease attributed to high fasting plasma glucose: Data from 1990 to 2019
Heliyon
Ischemic heart disease
High fasting plasma glucose
Mortality
Disability-adjusted life years
title The global burden of ischemic heart disease attributed to high fasting plasma glucose: Data from 1990 to 2019
title_full The global burden of ischemic heart disease attributed to high fasting plasma glucose: Data from 1990 to 2019
title_fullStr The global burden of ischemic heart disease attributed to high fasting plasma glucose: Data from 1990 to 2019
title_full_unstemmed The global burden of ischemic heart disease attributed to high fasting plasma glucose: Data from 1990 to 2019
title_short The global burden of ischemic heart disease attributed to high fasting plasma glucose: Data from 1990 to 2019
title_sort global burden of ischemic heart disease attributed to high fasting plasma glucose data from 1990 to 2019
topic Ischemic heart disease
High fasting plasma glucose
Mortality
Disability-adjusted life years
url http://www.sciencedirect.com/science/article/pii/S2405844024030962
work_keys_str_mv AT niruishen theglobalburdenofischemicheartdiseaseattributedtohighfastingplasmaglucosedatafrom1990to2019
AT jinliu theglobalburdenofischemicheartdiseaseattributedtohighfastingplasmaglucosedatafrom1990to2019
AT yanwang theglobalburdenofischemicheartdiseaseattributedtohighfastingplasmaglucosedatafrom1990to2019
AT yuanjieqiu theglobalburdenofischemicheartdiseaseattributedtohighfastingplasmaglucosedatafrom1990to2019
AT danyangli theglobalburdenofischemicheartdiseaseattributedtohighfastingplasmaglucosedatafrom1990to2019
AT qingtingwang theglobalburdenofischemicheartdiseaseattributedtohighfastingplasmaglucosedatafrom1990to2019
AT liminchai theglobalburdenofischemicheartdiseaseattributedtohighfastingplasmaglucosedatafrom1990to2019
AT yuqianchen theglobalburdenofischemicheartdiseaseattributedtohighfastingplasmaglucosedatafrom1990to2019
AT huizhonghu theglobalburdenofischemicheartdiseaseattributedtohighfastingplasmaglucosedatafrom1990to2019
AT manxiangli theglobalburdenofischemicheartdiseaseattributedtohighfastingplasmaglucosedatafrom1990to2019
AT niruishen globalburdenofischemicheartdiseaseattributedtohighfastingplasmaglucosedatafrom1990to2019
AT jinliu globalburdenofischemicheartdiseaseattributedtohighfastingplasmaglucosedatafrom1990to2019
AT yanwang globalburdenofischemicheartdiseaseattributedtohighfastingplasmaglucosedatafrom1990to2019
AT yuanjieqiu globalburdenofischemicheartdiseaseattributedtohighfastingplasmaglucosedatafrom1990to2019
AT danyangli globalburdenofischemicheartdiseaseattributedtohighfastingplasmaglucosedatafrom1990to2019
AT qingtingwang globalburdenofischemicheartdiseaseattributedtohighfastingplasmaglucosedatafrom1990to2019
AT liminchai globalburdenofischemicheartdiseaseattributedtohighfastingplasmaglucosedatafrom1990to2019
AT yuqianchen globalburdenofischemicheartdiseaseattributedtohighfastingplasmaglucosedatafrom1990to2019
AT huizhonghu globalburdenofischemicheartdiseaseattributedtohighfastingplasmaglucosedatafrom1990to2019
AT manxiangli globalburdenofischemicheartdiseaseattributedtohighfastingplasmaglucosedatafrom1990to2019